Asia Pacific Leukapheresis Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

No. of Pages: 137
Report Code: TIPRE00025791
Category: Life Sciences
Asia Pacific Leukapheresis Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Leukapheresis Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Leukapheresis Market Regional Analysis

6.2 Asia Pacific Leukapheresis Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Leukapheresis Market Forecast Analysis

7. Asia Pacific Leukapheresis Market Analysis – by Product Type

7.1 Leukapheresis Devices
  • 7.1.1 Overview
  • 7.1.2 Leukapheresis Devices: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Leukapheresis Disposables
  • 7.2.1 Overview
  • 7.2.2 Leukapheresis Disposables: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia Pacific Leukapheresis Market Analysis – by Application

8.1 Research Applications
  • 8.1.1 Overview
  • 8.1.2 Research Applications: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Therapeutic Applications
  • 8.2.1 Overview
  • 8.2.2 Therapeutic Applications: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia Pacific Leukapheresis Market Analysis – by End User

9.1 Blood Component Providers and Blood Centers
  • 9.1.1 Overview
  • 9.1.2 Blood Component Providers and Blood Centers: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Academic and Research Institutes
  • 9.2.1 Overview
  • 9.2.2 Academic and Research Institutes: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical and Biotechnology Companies
  • 9.3.1 Overview
  • 9.3.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Hospitals and Transfusion Centers
  • 9.4.1 Overview
  • 9.4.2 Hospitals and Transfusion Centers : Asia Pacific Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Asia Pacific Leukapheresis Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia Pacific Leukapheresis Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Asia Pacific Leukapheresis Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia Pacific Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 China: Asia Pacific Leukapheresis Market Breakdown, by Product Type
    • 10.2.1.1.2 China: Asia Pacific Leukapheresis Market Breakdown, by Application
    • 10.2.1.1.3 China: Asia Pacific Leukapheresis Market Breakdown, by End User
  • 10.2.1.2 India: Asia Pacific Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 India: Asia Pacific Leukapheresis Market Breakdown, by Product Type
    • 10.2.1.2.2 India: Asia Pacific Leukapheresis Market Breakdown, by Application
    • 10.2.1.2.3 India: Asia Pacific Leukapheresis Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia Pacific Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Japan: Asia Pacific Leukapheresis Market Breakdown, by Product Type
    • 10.2.1.3.2 Japan: Asia Pacific Leukapheresis Market Breakdown, by Application
    • 10.2.1.3.3 Japan: Asia Pacific Leukapheresis Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia Pacific Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Australia: Asia Pacific Leukapheresis Market Breakdown, by Product Type
    • 10.2.1.4.2 Australia: Asia Pacific Leukapheresis Market Breakdown, by Application
    • 10.2.1.4.3 Australia: Asia Pacific Leukapheresis Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Leukapheresis Market Breakdown, by Product Type
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Leukapheresis Market Breakdown, by Application
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Leukapheresis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Asahi Kasei Corporation
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Haemonetics Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Terumo Corporation
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 HemaCare
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Macopharma
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 AllCells
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 STEMEXPRESS
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 BioIVT
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia Pacific Leukapheresis Market

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • STEMEXPRESS
  • BioIVT
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)